Cargando…
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis
BACKGROUND: Controlling vascular growth is a challenging aim for the inhibition of tumor growth and metastasis. The amoeboid and mesenchymal types of invasiveness are two modes of migration interchangeable in cancer cells: the Rac-dependent mesenchymal migration requires the activity of proteases; t...
Autores principales: | Chillà, Anastasia, Margheri, Francesca, Biagioni, Alessio, Del Rosso, Mario, Fibbi, Gabriella, Laurenzana, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883600/ https://www.ncbi.nlm.nih.gov/pubmed/29615071 http://dx.doi.org/10.1186/s13046-018-0742-2 |
Ejemplares similares
-
Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis
por: Margheri, Francesca, et al.
Publicado: (2015) -
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling
por: Chillà, Anastasia, et al.
Publicado: (2023) -
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style
por: Margheri, Francesca, et al.
Publicado: (2014) -
Publisher Correction to: delivery systems of CRISPR/Cas9-based cancer gene therapy
por: Biagioni, Alessio, et al.
Publicado: (2019) -
Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma
por: Chillà, Anastasia, et al.
Publicado: (2020)